IDEAYA Biosciences grants 94,000 inducement stock options at $36.74 a share

Bitget2026/09/25 10:01

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

IDEAYA Biosciences granted non-qualified stock options for 94,000 shares to three newly hired employees on Sept. 24, 2026.
Options carry a $36.74 exercise price, matching the stock’s Nasdaq close on the grant date.
A 10-year term applies; 25% vests after one year, with the remainder vesting monthly over the next three years.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IDEAYA Biosciences Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: SF56753) on September 25, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

OpenAI CEO Altman stated that the IPO may only be considered after the company gains a clearer understanding of how to safely manage the "next-level AI." The delay in launching GPT-6.1 Astra is because the model did not meet some of the company’s evaluation criteria for safety; this decision was made "out of an abundance of caution" rather than due to any major incident. He also noted that Nvidia’s safety systems for AI are not a "complete solution;" AI is more of a scientific problem than an engineering one.

华尔街见闻•2026/09/29 20:11